A phase II, multicentre, randomized, two-arm blinded study to assess theefficacy and safety of two LXE408 regimens for treatment of patients with primary visceral leishmaniasis
An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild cases of COVID-19 - ANTICOV INDIA
A Prospective Feasibility Study to Evaluate the Safety and the efficacy of Ultrasound Ciliary Plasty in Refractory Glaucoma Patients.
100 Clinical Results associated with QAscent Research Solutions
0 Patents (Medical) associated with QAscent Research Solutions
100 Deals associated with QAscent Research Solutions
100 Translational Medicine associated with QAscent Research Solutions